NCT05403034

Brief Summary

The purpose of this prospective work is to study the consequences of obstetrical brachial plexus paralysis on the rotator muscles of the shoulder. The hypothesis is that shoulder stiffness of these children is due to an impairment of the shoulder rotator muscles. The investigators want to test the regenerative capacities of these muscles. The development of a cellular model of this pathology will allow to test new therapeutic perspectives and to validate our hypothesis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 26, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 3, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

October 17, 2022

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 25, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2025

Completed
Last Updated

April 24, 2026

Status Verified

September 1, 2025

Enrollment Period

2.7 years

First QC Date

April 26, 2022

Last Update Submit

April 21, 2026

Conditions

Keywords

Brachial plexusNeonatal brachial plexus palsyDenervationMuscle atrophyMuscle regenerationBotulinum toxinSatellite cellPrimary human muscle cell culture

Outcome Measures

Primary Outcomes (2)

  • Assessment of muscle regeneration capacity: proliferation capacity

    Proliferation capacity of satellite cells assessed by immunofluorescence: percentage of Pax 7 positive cells/total desmin positive cells

    30 days

  • assessment of muscle regeneration capacity: differenciation capacity

    Differentiation capacity of satellite cells assessed by histology: fusion index (number of nuclei in a myotubule compared to total number of nuclei in the sample) in percentage

    30 days

Secondary Outcomes (2)

  • Effect of botulinum toxin on the proliferation potential of satellite cells: proliferation capacity

    30 days

  • Effect of botulinum toxin on the proliferation potential of satellite cells: differentiation capacity

    30 days

Study Arms (1)

OBPP children

EXPERIMENTAL

OBPP children operated on to treat shoulder stiffness.

Procedure: Muscle biopsy

Interventions

Muscle biopsyPROCEDURE

Peroperative muscle biopsy will be performed during a planned shoulder surgery (arthrolysis and/or muscle transfer)

Also known as: Shoulder arthrolysis, Shoulder muscle transfer
OBPP children

Eligibility Criteria

Age2 Years - 15 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • OBPP children with a planned shoulder surgery (arthrolysis and/or muscle transfer).

You may not qualify if:

  • other neurological disorders, post-traumatic shoulder stiffness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chu Montpellier

Montpellier, 34000, France

Location

Related Publications (1)

  • Douillard M, Deheb Z, Bozon A, Raison-Peyron N, Dereure O, Moulis L, Soria A, Du-Thanh A. Over diagnosis of bradykinin angioedema in patients treated with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers. World Allergy Organ J. 2023 Aug 19;16(8):100809. doi: 10.1016/j.waojou.2023.100809. eCollection 2023 Aug.

Related Links

MeSH Terms

Conditions

Neonatal Brachial Plexus PalsyMuscular Atrophy

Condition Hierarchy (Ancestors)

Brachial Plexus NeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesBirth InjuriesInfant, Newborn, DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesWounds and InjuriesNeuromuscular ManifestationsNeurologic ManifestationsAtrophyPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsSigns and Symptoms

Study Officials

  • Marion DELPONT, Dr

    University Hospital, Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 26, 2022

First Posted

June 3, 2022

Study Start

October 17, 2022

Primary Completion

June 25, 2025

Study Completion

June 25, 2025

Last Updated

April 24, 2026

Record last verified: 2025-09

Locations